Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Gaylord Palms Resort & Convention Center

Mar 21, 2016 1:00 PM - Mar 23, 2016 4:30 PM

6000 West Osceola Parkway, Kissimmee, FL 34746

Medical Affairs and Scientific Communications 2016 Annual Forum

Cross-functional forum spotlights topics related to medical communication, medical science liaison, medical call center, and medical writing professionals.

Session 6 Track C: Value of the Medical Science Liaison Role (MSL) Across the Product Life Cycle - From Early Trial Execution to Patent Expiry

Session Chair(s)

Jim  Wilkinson, PhD

Jim Wilkinson, PhD

U.S. Medical Affairs Lead, Medical Affairs & Evidence Generation

Argenx, United States

The value proposition of a function to the organization must be clear, aligned, and consistently communicated to both internal and external stakeholders. In this session, we will discuss the different roles and value the MSL can bring along the product life cycle. Specific examples will be provided of best practices when working with programs pre-approval, around the peri-launch timeframe, and those mature products approaching patent expiry. We will discuss effectively working with study operations and clinical development, CROs, early development, OL engagement, disease state education, ISS/ISTs, product launches, HEOR for mature products, and metrics across the life cycle.

Learning Objective :
  • Describe the value of field-based medical teams, in the context of different stages of product development, to benefit the whole organizationM/LI>
  • Identify best practices in a highly-regulated environment and how to flex activities based upon the phase of the supported product or program
  • Evaluate specific examples of functional value implemented in the field that support internal, as well as, external customers

Speaker(s)

Richard  Swank, PhD

MSL Roles in Clinical Research, Working With Study Operations, and Early OL Identification/Profiling, etc.

Richard Swank, PhD

Scientific Engagement LLC, United States

Founder

Valerie Ann Stafford-Fox, MBA, MSN, RN

MSL Roles in Preparing for Product Launch: Disease State Education, OL Engagement, and Launch Measurements of Success

Valerie Ann Stafford-Fox, MBA, MSN, RN

Genentech, A Member of the Roche Group, United States

Associate Director, BioOncology Women's Health Medical Science Liaison Team

Ralph  Rewers, PharmD

Mature Product Support, Life Cycle Management, OL Engagement With Limited New Data, HEOR, and “Right-Sizing” a Team When Approaching for Patent Expiry

Ralph Rewers, PharmD

Abbvie, United States

US Medical Science Liaison, Head

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.